7-Ketocholesterol predisposes human aorta smooth muscle cells to Fas-mediated death

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 5, 2005, Pages 823-832

  Rho, Mun Chual ^a   Young, Kook Kim ^a   Jong, Sun Chang ^a,d   Hyun, Sun Lee ^a   Jin, Ah Baek ^a   Mi, Yeon Chung ^a   Han, Cheol Lee ^b   Hwan, Woo Lee ^b   Byong, Yong Rhim ^b   Reidy, Michael A ^c   Kim, Koanhoi ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Pusan National University   (South Korea)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Columbia University ^*  (United States)

Author keywords

7 Ketocholesterol; Apoptosis; Atherosclerosis; Fas; Vascular smooth muscle cell

Indexed keywords

7 OXOCHOLESTEROL; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DNA FRAGMENT; FAS ANTIBODY; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN BAX; PROTEIN P37;

ADENOVIRUS; AGONIST; AORTA ATHEROSCLEROSIS; AORTA INJURY; AORTA MEDIA; ARTICLE; BACULOVIRUS; CELL DEATH; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA STRAND; HEART MITOCHONDRION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD95; AORTA; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL DEATH; CELL SHAPE; CYTOCHROMES C; CYTOSOL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; KETOCHOLESTEROLS; MEMBRANE POTENTIALS; MITOCHONDRIA; MYOCYTES, SMOOTH MUSCLE; PROTEIN TRANSPORT; TIME FACTORS;

EID: 26844547130     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.07.018     Document Type: Article

References (42)

1. A. Cho, D.W. Courtman, and B.L. Langille Apoptosis (programmed cell death) in arteries of the neonatal lamb Circ. Res. 76 1995 168 175
2. M.M. Kockx, and A.G. Herman Apoptosis in atherogenesis: implications for plaque destabilization Eur. Heart J. 19 Suppl G 1998 G23 G28
3. P. Libby Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2001 365 372
4. M. Crisby, B. Kallin, J. Thyberg, B. Zhivotovsky, S. Orrenius, and V. Kostulas Cell death in human atherosclerotic plaques involves both oncosis and apoptosis Atherosclerosis 130 1997 17 27
5. D.L. Vaux, and S.J. Korsmeyer Cell death in development Cell 96 1999 245 254
6. P.D. Flynn, C.D. Byrne, T.P. Baglin, P.L. Weissberg, and M.R. Bennett Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 1997 4378 4384
7. D. Proudfoot, J.N. Skepper, L. Hegyi, M.R. Bennett, C.M. Shanahan, and P.L. Weissberg Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies Circ. Res. 87 2000 1055 1062
8. A. Lafont, and P. Libby The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J. Am. Coll. Cardiol. 32 1998 283 285
9. E.R. Miller 3rd, T.P. Erlinger, R.S. Blumenthal, S. Margolis, and J.K. Allen Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization Coron. Artery Dis. 14 2003 163 169
10. M. Fukumoto, T. Shoji, M. Emoto, T. Kawagishi, Y. Okuno, and Y. Nishizawa Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population Arterioscler. Thromb. Vasc. Biol. 20 2000 703 707
11. C.C. Hsieh, M.H. Yen, C.H. Yen, and Y.T. Lau Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells Cardiovasc. Res. 49 2001 135 145
12. S. Horkko, C.J. Binder, P.X. Shaw, M.K. Chang, G. Silverman, and W. Palinski Immunological responses to oxidized LDL Free Radic. Biol. Med. 28 2000 1771 1779
13. D. Steinberg, and J.L. Witztum Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105 2002 2107 2111
14. C. Napoli, O. Quehenberger, F. De Nigris, P. Abete, C.K. Glass, and W. Palinski Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells FASEB J. 14 2000 1996 2007
15. S. Garcia-Cruset, K.L. Carpenter, F. Guardiola, and M.J. Mitchinson Oxysterols in cap and core of human advanced atherosclerotic lesions Free Radic. Res. 30 1999 341 350
16. J. Yin, X. Chaufour, C. McLachlan, M. McGuire, G. White, and N. King Apoptosis of vascular smooth muscle cells induced by cholesterol and its oxides in vitro and in vivo Atherosclerosis 148 2000 365 374
17. G. Lizard, S. Monier, C. Cordelet, L. Gesquiere, V. Deckert, and S. Gueldry Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall Arterioscler. Thromb. Vasc. Biol. 19 1999 1190 1200
18. G. Lizard, S. Gueldry, O. Sordet, S. Monier, A. Athias, and C. Miguet Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production FASEB J. 12 1998 1651 1663
19. W. Martinet, M. De Bie, D.M. Schrijvers, G.R. De Meyer, A.G. Herman, and M.M. Kockx 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 24 2004 2296 2301
20. C.I. Seye, M.W. Knaapen, D. Daret, C. Desgranges, A.G. Herman, and M.M. Kockx 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling Cardiovasc. Res. 64 2004 144 153
21. W. Cai, B. Devaux, W. Schaper, and J. Schaper The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions Atherosclerosis 131 1997 177 186
22. Y.J. Geng, L.E. Henderson, E.B. Levesque, M. Muszynski, and P. Libby Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 17 1997 2200 2208
23. S.W. Chan, L. Hegyi, S. Scott, N.R. Cary, P.L. Weissberg, and M.R. Bennett Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells Circ. Res. 86 2000 1038 1046
24. J.J. Boyle, D.E. Bowyer, P.L. Weissberg, and M.R. Bennett Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions Arterioscler. Thromb. Vasc. Biol. 21 2001 1402 1407
25. K. Kim Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death Biochem. Biophys. Res. Commun. 281 2001 305 310
26. A.C. Knapp, J. Huang, G. Starling, and P.A. Kiener Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death Atherosclerosis 152 2000 217 227
27. P. Marchetti, M. Castedo, S.A. Susin, N. Zamzami, T. Hirsch, and A. Macho Mitochondrial permeability transition is a central coordinating event of apoptosis J. Exp. Med. 184 1996 1155 1160
28. C.M. Jabs, W.J. Ferrell, and H.J. Robb Microdetermination of plasma ATP and creatine phosphate concentrations with a luminescence biometer Clin. Chem. 23 1977 2254 2257
29. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc. Natl. Acad. Sci. USA 95 1998 2509 2514
30. A.M. Chinnaiyan, C.G. Tepper, M.F. Seldin, K. O'Rourke, F.C. Kischkel, and S. Hellbardt FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis J. Biol. Chem. 271 1996 4961 4965
31. D.R. Beidler, M. Tewari, P.D. Friesen, G. Poirier, and V.M. Dixit The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis J. Biol. Chem. 270 1995 16526 16528
32. Y.C. O'Callaghan, J.A. Woods, and N.M. O'Brien Comparative study of the cytotoxicity and apoptosis-inducing potential of commonly occurring oxysterols Cell Biol. Toxicol. 17 2001 127 137
33. S. Lemaire, G. Lizard, S. Monier, C. Miguet, S. Gueldry, and F. Volot Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol FEBS Lett. 440 1998 434 439
34. A. Sevanian, G. Bittolo-Bon, G. Cazzolato, H. Hodis, J. Hwang, and A. Zamburlini LDL- is a lipid hydroperoxide-enriched circulating lipoprotein J. Lipid Res. 38 1997 419 428
35. G.J. Schroepfer Jr. Oxysterols: modulators of cholesterol metabolism and other processes Physiol. Rev. 80 2000 361 554
36. M. Bennett, K. Macdonald, S.W. Chan, J.P. Luzio, R. Simari, and P. Weissberg Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis Science 282 1998 290 293
37. W. Roth, S. Isenmann, M. Nakamura, M. Platten, W. Wick, and P. Kleihues Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis Cancer Res. 61 2001 2759 2765
38. R.M. Pitti, S.A. Marsters, D.A. Lawrence, M. Roy, F.C. Kischkel, and P. Dowd Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature 396 1998 699 703
39. S. Takada, Y. Shirakata, N. Kaneniwa, and K. Koike Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death Oncogene 18 1999 6965 6973
40. N. Haga, N. Fujita, and T. Tsuruo Mitochondrial aggregation precedes cytochrome c release from mitochondria during apoptosis Oncogene 22 2003 5579 5585
41. C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li, and K.J. Tomaselli Two CD95 (APO-1/Fas) signaling pathways EMBO J. 17 1998 1675 1687
42. T. Kuwana, M.R. Mackey, G. Perkins, M.H. Ellisman, M. Latterich, and R. Schneiter Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane Cell 111 2002 331 342